Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication

Cell Reports

Volumn 15, Issue 4, 2016, Pages 879-892

  Lahaye, Xavier ^a   Satoh, Takeshi ^a   Gentili, Matteo ^a   Cerboni, Silvia ^a   Silvin, Aymeric ^a   Conrad, Cécile ^a   Ahmed Belkacem, Abdelhakim ^b   Rodriguez, Elisa C ^c   Guichou, Jean François ^d   Bosquet, Nathalie ^e   Piel, Matthieu ^f,g   Le Grand, Roger ^e   King, Megan C ^c   Pawlotsky, Jean Michel ^b,h   Manel, Nicolas ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSERM U955   (France)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INSTITUT CURIE   (France)

^g PSL RESEARCH UNIVERSITY   (France)

^h HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; ENVELOPE PROTEIN; SUN2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA TRANSCRIPTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CAPSID; VIRUS MUTANT; VIRUS REPLICATION;

EID: 84963621155     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.03.074     Document Type: Article

References (59)

1. Aberham C., Weber S., Phares W. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J. Virol. 1996, 70:3536-3544.
2. Ambrose Z., Lee K., Ndjomou J., Xu H., Oztop I., Matous J., Takemura T., Unutmaz D., Engelman A., Hughes S.H., KewalRamani V.N. Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J. Virol. 2012, 86:4708-4714.
3. Bieniasz P.D. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 2004, 5:1109-1115.
4. Billich A., Hammerschmid F., Peichl P., Wenger R., Zenke G., Quesniaux V., Rosenwirth B. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. J. Virol. 1995, 69:2451-2461.
5. Bock M., Bishop K.N., Towers G., Stoye J.P. Use of a transient assay for studying the genetic determinants of Fv1 restriction. J. Virol. 2000, 74:7422-7430.
6. Bosco D.A., Eisenmesser E.Z., Pochapsky S., Sundquist W.I., Kern D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. USA 2002, 99:5247-5252.
7. Braaten D., Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 2001, 20:1300-1309.
8. Braaten D., Franke E.K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 1996, 70:3551-3560.
9. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
10. Campbell E.M., Hope T.J. HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat. Rev. Microbiol. 2015, 13:471-483.
11. Chin C.R., Perreira J.M., Savidis G., Portmann J.M., Aker A.M., Feeley E.M., Smith M.C., Brass A.L. Direct visualization of HIV-1 replication intermediates shows that Capsid and CPSF6 modulate HIV-1 intra-nuclear invasion and integration. Cell Rep. 2015, 13:1717-1731.
12. De Iaco A., Luban J. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. Retrovirology 2014, 11:11.
13. Di Nunzio F., Danckaert A., Fricke T., Perez P., Fernandez J., Perret E., Roux P., Shorte S., Charneau P., Diaz-Griffero F., Arhel N.J. Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration. PLoS ONE 2012, 7:e46037.
14. Donahue D.A., Amraoui S., di Nunzio F., Kieffer C., Porrot F., Opp S., Diaz-Griffero F., Casartelli N., Schwartz O. SUN2 overexpression deforms nuclear shape and inhibits HIV. J. Virol. 2016, Published online February 10, 2016. JVI.03202-15.
15. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372:359-362.
16. Ganser-Pornillos B.K., Chandrasekaran V., Pornillos O., Sodroski J.G., Sundquist W.I., Yeager M. Hexagonal assembly of a restricting TRIM5alpha protein. Proc. Natl. Acad. Sci. USA 2011, 108:534-539.
17. Gaudin R., de Alencar B.C., Arhel N., Benaroch P. HIV trafficking in host cells: motors wanted!. Trends Cell Biol. 2013, 23:652-662.
18. Goldstone D.C., Yap M.W., Robertson L.E., Haire L.F., Taylor W.R., Katzourakis A., Stoye J.P., Taylor I.A. Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host Microbe 2010, 8:248-259.
19. Goujon C., Moncorgé O., Bauby H., Doyle T., Ward C.C., Schaller T., Hué S., Barclay W.S., Schulz R., Malim M.H. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013, 502:559-562.
20. Hilditch L., Towers G.J. A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr. Opin. Virol. 2014, 4:32-36.
21. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
22. Kane M., Yadav S.S., Bitzegeio J., Kutluay S.B., Zang T., Wilson S.J., Schoggins J.W., Rice C.M., Yamashita M., Hatziioannou T., Bieniasz P.D. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013, 502:563-566.
23. Krishnan L., Matreyek K.A., Oztop I., Lee K., Tipper C.H., Li X., Dar M.J., Kewalramani V.N., Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J. Virol. 2010, 84:397-406.
24. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Ségéral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
25. Lahaye X., Satoh T., Gentili M., Cerboni S., Conrad C., Hurbain I., El Marjou A., Lacabaratz C., Lelièvre J.D., Manel N. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013, 39:1132-1142.
26. Lee K., Ambrose Z., Martin T.D., Oztop I., Mulky A., Julias J.G., Vandegraaff N., Baumann J.G., Wang R., Yuen W., et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7:221-233.
27. Lei K., Zhang X., Ding X., Guo X., Chen M., Zhu B., Xu T., Zhuang Y., Xu R., Han M. SUN1 and SUN2 play critical but partially redundant roles in anchoring nuclei in skeletal muscle cells in mice. Proc. Natl. Acad. Sci. USA 2009, 106:10207-10212.
28. Lin T.Y., Emerman M. Cyclophilin A interacts with diverse lentiviral capsids. Retrovirology 2006, 3:70.
29. Liu Q., Pante N., Misteli T., Elsagga M., Crisp M., Hodzic D., Burke B., Roux K.J. Functional association of Sun1 with nuclear pore complexes. J. Cell Biol. 2007, 178:785-798.
30. Liu Z., Pan Q., Ding S., Qian J., Xu F., Zhou J., Cen S., Guo F., Liang C. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013, 14:398-410.
31. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
32. Malim M.H., Bieniasz P.D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2012, 2:a006940.
33. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467:214-217.
34. Matreyek K.A., Engelman A. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. J. Virol. 2011, 85:7818-7827.
35. Matreyek K.A., Yücel S.S., Li X., Engelman A. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog. 2013, 9:e1003693.
36. Meehan A.M., Saenz D.T., Guevera R., Morrison J.H., Peretz M., Fadel H.J., Hamada M., van Deursen J., Poeschla E.M. A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathog. 2014, 10:e1003969.
37. Nisole S., Lynch C., Stoye J.P., Yap M.W. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. USA 2004, 101:13324-13328.
38. O'Doherty U., Ignatius R., Bhardwaj N., Pope M. Generation of monocyte-derived dendritic cells from precursors in rhesus macaque blood. J. Immunol. Methods 1997, 207:185-194.
39. Pizzato M., Erlwein O., Bonsall D., Kaye S., Muir D., McClure M.O. A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J. Virol. Methods 2009, 156:1-7.
40. Price A.J., Marzetta F., Lammers M., Ylinen L.M., Schaller T., Wilson S.J., Towers G.J., James L.C. Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat. Struct. Mol. Biol. 2009, 16:1036-1042.
41. Price A.J., Fletcher A.J., Schaller T., Elliott T., Lee K., KewalRamani V.N., Chin J.W., Towers G.J., James L.C. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 2012, 8:e1002896. Published online August 30, 2012.
42. Qi M., Yang R., Aiken C. Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells. J. Virol. 2008, 82:12001-12008.
43. Rasaiyaah J., Tan C.P., Fletcher A.J., Price A.J., Blondeau C., Hilditch L., Jacques D.A., Selwood D.L., James L.C., Noursadeghi M., Towers G.J. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503:402-405.
44. Saini M., Potash M.J. Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages. J. Immunol. 2006, 177:443-449.
45. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
46. Schaller T., Ocwieja K.E., Rasaiyaah J., Price A.J., Brady T.L., Roth S.L., Hué S., Fletcher A.J., Lee K., KewalRamani V.N., et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011, 7:e1002439.
47. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
48. Sokolskaja E., Luban J. Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr. Opin. Microbiol. 2006, 9:404-408.
49. Sokolskaja E., Sayah D.M., Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J. Virol. 2004, 78:12800-12808.
50. Song C., Aiken C. Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant. J. Virol. 2007, 81:11946-11956.
51. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
52. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Göttlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
53. Towers G.J., Hatziioannou T., Cowan S., Goff S.P., Luban J., Bieniasz P.D. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 2003, 9:1138-1143.
54. Tzur Y.B., Wilson K.L., Gruenbaum Y. SUN-domain proteins: 'Velcro' that links the nucleoskeleton to the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2006, 7:782-788.
55. Virgen C.A., Kratovac Z., Bieniasz P.D., Hatziioannou T. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. USA 2008, 105:3563-3568.
56. Yamashita M., Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 2004, 78:5670-5678.
57. Yang R., Aiken C. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. J. Virol. 2007, 81:3749-3756.
58. Yin L., Braaten D., Luban J. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J. Virol. 1998, 72:6430-6436.
59. Yoo S., Myszka D.G., Yeh C., McMurray M., Hill C.P., Sundquist W.I. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 1997, 269:780-795.